ArticleFrontiers in medicine2026
Brucellosis associated with acute kidney injury and pancytopenia: a case report and review of the literature.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brucella infection frequently involves multiple organ systems, such as muscles, bones, liver, spleen, gastrointestinal tract, and others. Its clinical manifestations lack specificity. Acute kidney injury complicated by haemophagocytic syndrome is particularly rare in the course of brucellosis. We described a 51-year-old man with brucellosis presenting with acute kidney injury and haemophagocytic syndrome. His primary manifestations included unexplained fever, progressive pancytopenia, progressive elevation of serum creatinine, imaging demonstrating increased renal cortical echogenicity, and positive blood culture results for Brucella. Following combined anti-Brucella therapy and etoposide (VP-16) chemotherapy, the patient's symptoms and renal function improved significantly. This case highlights the need to consider rare pathogens in cases of unexplained fever, as the clinical features of haemophagocytic syndrome lack specificity. Detailed history-taking, definitive laboratory findings, and awareness of rare complications of brucellosis facilitate early diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.